Trinity Biotech Growth Metrics (2017-2024) | TRIB

Growth Metrics Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Growth Ratios
Assets Growth (1y) (Quarter) -22.68%-21.41%-13.58%-0.51%-8.82%-22.53%-35.47%73.79%
Assets Growth (3y) (Quarter) -19.32%-12.25%-7.79%-11.10%-23.04%-4.58%
Assets Growth (5y) (Quarter) -13.78%-13.75%-17.08%-4.65%
Cash & Equivalents Growth (1y) (Quarter) -25.29%-47.44%-45.83%66.63%-5.19%-74.61%-43.89%39.99%
Cash & Equivalents Growth (3y) (Quarter) -40.31%-22.01%-5.06%-26.25%-48.69%-41.58%
Cash & Equivalents Growth (5y) (Quarter) -19.60%-35.21%-34.35%-20.63%
Enterprise Value Growth (1y) (Quarter) -18.86%66.96%41.97%-55.54%5.19%74.61%43.89%-39.99%
Enterprise Value Growth (3y) (Quarter) 38.92%33.19%5.06%27.93%48.69%41.58%
Enterprise Value Growth (5y) (Quarter) 19.60%40.95%34.35%21.71%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -56.73%-7.55%73.26%-8.00%-30.76%-3.99%-66.70%144.24%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) -11.50%13.80%3.34%-15.12%-39.51%-7.92%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) -15.08%-0.41%-18.81%-13.04%
Shareholder's Equity Growth (1y) (Quarter) -40.04%-32.43%-89.30%-147.08%
Shareholder's Equity Growth (3y) (Quarter) -64.87%-26.70%
Total Debt Growth (1y) (Quarter) 0.78%-12.45%0.79%-99.96%0.00%
Total Debt Growth (3y) (Quarter) -3.84%-93.07%-92.75%
Total Debt Growth (5y) (Quarter) -79.80%